Janux Therapeutics, Inc. (JANX) shares rallied 8.8% in the last trading session to close at $29.76. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 15.4% gain over the past four weeks.The price rise can be attributed to growing investor confidence in the company’s pipeline. The most advanced candidates in Janux’s pipeline are JANX007 and JANX008, which are being evaluated in early-stage clinical studies for p ...